Patents by Inventor Murray W. Drulak

Murray W. Drulak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of cancer with thalidomide alone or in combination with other anti-cancer agents
    Patent number: 6140346
    Abstract: A method is provided for the treatment of neoplastic diseases in a mammal which comprises administering to said mammal a therapeutically effective amount of thalidomide. The method also uses a combination of thalidomide with other anti-neoplastic agents. Additionally, pharmaceutical compositions containing thalidomide and other anti-cancer agents are also provided.
    Type: Grant
    Filed: May 4, 1998
    Date of Patent: October 31, 2000
    Assignee: Andrulis Pharmaceuticals Corp.
    Inventors: Peter J. Andrulis, Jr., Murray W. Drulak
  • Treatment of melanomas with thalidomide alone or in combination with other anti-melanoma agents
    Patent number: 5731325
    Abstract: A method for treatment of malignant melanoma by administering an effective amount of thalidomide alone or in combination with other anti-melanoma drugs.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: March 24, 1998
    Assignee: Andrulis Pharmaceuticals Corp.
    Inventors: Peter J. Andrulis, Jr., Murray W. Drulak
  • Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agents
    Patent number: 5654312
    Abstract: Methods of treatment for inflammatory and autoimmune dermatoses which comprises topical and/or systemic administration of a therapeutically-effective amount of thalidomide alone or in combination with other dermatological agents.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 5, 1997
    Assignee: Andrulis Pharmaceuticals
    Inventors: Peter J. Andrulis, Jr., Murray W. Drulak
  • Treatment of ischemia/reperfusion injury with thalidomide alone or in combination with other therapies
    Patent number: 5643915
    Abstract: In accordance with the present invention, a method is provided for treating reperfusion injury, ischemia and runaway inflammatory conditions with thalidomide alone or in combination with other drugs selected from the group consisting of nitrates, beta-adrenoceptor blocking agents, anti-platelet/thrombolytic drugs, drugs acting as the arachindonic acid cascade and calcium antagonists. Pharmaceutical compositions comprising thalidomide alone or in combination with other drugs are also provided.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: July 1, 1997
    Assignee: Andrulis Pharmaceuticals Corp.
    Inventors: Peter J. Andrulis, Jr., Murray W. Drulak